PROK Prokidney Corp. - 8-K

Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 28, 2026, ProKidney Corp. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). The matters voted on at the Annual Meeting and the votes cast with respect to each such matter are set forth below:

(1)

Based on the following results of the voting, the Company’s stockholders elected the nominees listed below to the Company’s Board of Directors, each to serve for a three-year term to expire at the Company’s annual meeting of stockholders in 2029 and until their successors are duly elected and qualified:

Director Nominee

For

Withhold

Broker Non Votes

William F. Doyle

196,164,585

1,459,235

42,579,394

Alan M. Lotvin, M.D.

193,179,768

4,444,052

42,579,394

Brian J.G. Pereira

197,002,580

621,240

42,579,394

(2)

The appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified based on the following results of the voting:

For

Against

Abstain

Broker Non Votes

239,091,167

729,165

382,882

–